Loading company…
Glasgow-based Novel Technologies sells SILVERbac antimicrobial products for hotel linens, uniforms and medical textiles.
Founded in 2017 by David Evans and based in Glasgow, UK, Novel Technologies Holdings Limited develops antimicrobial technology under its SILVERbac brand, which releases ions to inhibit 99.9% of bacterial pathogens. Products serve hotels and healthcare facilities across the UK, EU and USA, sold as bulk orders to B2B clients. In February 2020 the company raised GBP 0.5 million from Foresight Group Holdings, bringing total venture funding to GBP 2.1 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in